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Drosophila melanogaster has been a classic model organism for the studies of genetics. More than 15,000
Drosophila genes have been annotated since the entire genome was sequenced; however, many of them still lack
functional characterization. Various gene-manipulating approaches in Drosophila have been developed for the
function analysis of genes. Here, we summarize some representative strategies utilized for Drosophila gene
targeting, from the unbiased ethyl methanesulfonate (EMS) mutagenesis and transposable element insertion, to
insertional/replacement homologous recombination and site-specific nucleases such as the zinc-finger nuclease
(ZFN), the transcription activator-like effector nuclease (TALEN) and the CRISPR (clustered regularly interspaced short
palindromic repeats)/Cas9 system. Specifically, we evaluate the pros and cons of each technique in a historical
perspective. This review discuss important factors that should be taken into consideration for the selection of a
strategy that best fits the specific needs of a gene knockout project.
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Drosophila melanogaster is a well-studied model organism.
Because 75% of human disease genes have counterparts in
the Drosophila genome [1,2], fruit flies has been used as a
genetic model to study physiological mechanisms and
pathological conditions such as aging [3], diabetes [4], neu-
rodegenerative disorders [5], and cancer [6]. With more
than 15,000 annotated genes [7], merely 37% of Drosophila
genes that have obvious phenotypes are further studied,
while the remaining still awaits future investigation [7,8].
Conventional unbiased forward genetic screens with the
employment of ethyl methanesulfonate (EMS) [9] or X-
rays [10] have successfully uncovered numerous mutants
based on various visible phenotypes. Random-insertion of
P-elements is another common method to generate mu-
tants by creating deletions following the excision of P-
elements. As for targeted mutagenesis, fly biologists have
mainly relied on two forms of homologous recombination-
based gene targeting: insertional (“Ends-In”) [11] and re-
placement (“Ends-Out) [12], for the past decade. Although
the aforementioned approaches are powerful in identifying
novel functions of the annotated genes, large-scale genetic* Correspondence: chancc1@ntu.edu.tw
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and time-consuming.
In recent years, several sequence-guided DNA endo-
nucleases have been applied to generating targeted mu-
tations in model organisms including Drosophila [13].
These site-specific nucleases are programmable, that is,
they can induce DNA double-strand breaks (DSBs) that
stimulate non-homologous ends-joining (NHEJ) and/or
subsequent homologous recombination (HR) at targeted
loci [14], therefore generate a frame-shift mutation or a
replacement with an extragenous null allele. This type of
gene knockout techniques includes the zinc-finger nucle-
ase (ZFN) [13], the transcription activator-like effector nu-
clease (TALEN) [15], and the CRISPR (clustered regularly
interspaced short palindromic repeats)/Cas9 systems
[16-18]. Particularly, CRISPR/Cas9 has drawn the atten-
tions of Drosophila biologists because it greatly reduces
the time and financial requirement, and makes genome-
wide gene knockout projects much more practical. Below
we will summarize these important approaches in gene
disruption, discuss the pros and cons of each technique,
and end with emphasis on the applications and future
challenges of CRISPR/Cas9 system.EMS mutagenesis
The use of potential DNA alkylating agents, especially
EMS, has been a standard approach for mutagenesis. This is an Open Access article distributed under the terms of the Creative
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model organisms. EMS induces new mutations, mostly
GC to AT transitions [19], once every ~400 kb at ran-
dom sites of Drosophila genome [20]. As EMS shows no
preference for coding sequence, it is able to disrupt
genes unbiasedly and to create mutations of various na-
ture in one gene. Besides, the relative low-cost makes
EMS the most commonly used reagent to survey all
genes in a mutagenesis scheme aiming to saturate the
whole Drosophila genome [9]. Although the ease of use
is appealing, several potential pitfalls of EMS mutagen-
esis should be taken into consideration. First, its
phenotype-based approach narrows the investigations to
certain discernible phenotypes, such as the changes of
eye colors, organ sizes or wing shapes. In this way, mu-
tations generated by EMS may be either overlooked be-
cause of the subtle phenotypes or unable to recover due
to the lethality. Second, most cases of EMS-based muta-
genesis result in point mutations. For a given gene, a
single point mutation may only generate a hypomorphic
allele with subtle phenotypes. Therefore, the effects of a
gene may be underestimated by simply analyzing the
hypomorphic mutants, which may lead to an underesti-
mation in the effects of a gene. Third, mapping the mu-
tations induced by EMS is fairly challenging since the
mutated loci are not tagged with recognizable sequences,
unlike some other approaches such as P-element-
mediated disruptions (the details will be discussed later).
Besides, EMS often mutates only one strand of the DNA
and leaves the unmutated complementary strand, thus
causing genetic mosaic in the progeny after rounds of
DNA replications [9]. In order to limit the coverage of
the genome and to ensure that the phenotype of interest
can be transmitted to future generations, screenings fol-
lowing EMS mutagenesis commonly focus on individual
chromosomes or chromosome arms. Since the location
of an EMS mutation now can be better determined by
using high-resolution, high-throughput SNP mapping,
identifying the hits from the EMS screening has become
relatively promising and more appealing to researchers
[21]. Lastly, as EMS may produce multiple hits in the
gene of interest [20], verifying the mutation responsible
for the scored phenotype requires laborious complemen-
tation tests or full-genome sequencing. The time and ef-
fort has been considerably reduced nowadays in order to
plot the molecular nature of an EMS mutation since the
Drosophila genome sequence was released and next-
generation sequencing became available [20]. Undoubt-
edly, EMS mutagenesis is still considered a powerful tool
for Drosophila gene manipulating.
Transposon-mediated mutagenesis
Transposons are pieces of DNA that are mobile in the ge-
nomes. Taking the nature of mobility, several transposonshave been employed for gene disruption and modification
in Drosophila, including P-elements, piggyBacs and Minos.
Traditionally, P-elements are extensively used for forward
mutagenesis either by direct gene disruptions following
the insertions or via the imprecise excisions after the sec-
ond translocation events. As the class II transposon, a
P-element moves in the genome through a DNA-based
"cut and paste" mechanism and tends to insert near ac-
tively transcribed genes, where the chromatin structure is
relatively loose [22]. Each P-element encodes a protein
called P transposase, which recognizes the inverted re-
peats of P-element and mobilize itself from the original
site. An engineered exogenous P-element for mutagen-
esis contains an internal deletion that abolishes the
translation of the transposase, but such P-elements
inserted in the genome can also be mobilized by
addition of the transposase gene in the other chromo-
some via a cross [23]. The mobilized P-elements some-
times remove the flanking DNA, creating a deletion
where P-elements have originally been integrated [24].
Thus, despite P-element insertions may not completely
disrupt the function of genes; loss-of-function alleles are
often generated by the imprecise excision (Figure 1).
The transposon-based gene disruption has several ad-
vantages that outrank EMS mutagenesis. First, the oc-
currence of second-site mutations in each individual is
relatively low in the P-element system. Visible markers,
such as white+, may be engineered to be a part of the
transposon, and multi-transposition events can be easily
selected out by the presence or absence of markers at
the early stages of screening. Second, P-elements show
high frequency of mobilization, and they can be modu-
lated via the expression of active transposases that are
controlled temporally and spatially. Third, the screen effi-
ciency for the transposon-based mutagenesis largely de-
pends on the marker(s) that can be scored. For example,
P-element insertions with white+, as mentioned above,
allow molecular mapping by scoring the eye color. Add-
itionally, the insertion sites could be mapped by calculating
the recombination rate between different P-element inser-
tions [25], or directly identified by techniques such as in-
verse PCR [26] or splinkerette PCR [27].
The main disadvantage of P-element-mediated gene
disruption is its preference for inserting into “hotspots”,
which largely reside in the promotor regions of some genes
[28]. Regardless of original insertion loci and the nature of
sequence composition, 30–40% of the P-elements land in
the same 200–400 genomic hotspots, making the genome-
wide, saturated disruption scheme by P-elements less
feasible. Interestingly, the preference for hotspots ap-
pears to be unique to P-elements and is evidently absent
in other transposons, such as piggyBac or Minos, since
piggyBac favorably targets TTAA sequences while Minos
inserts at random [29]. Although P-elements have once
Figure 1 The scheme of P-element transposition. The illustrations show a model of P-element mediated transposition. First, the transposase
binds to sequences within both P-element termini and initiates a DSB at each end. The excised P-element could be translocated into a new target
site to disrupt another gene (left). Gap repair can then generate duplicated target sites with the P-element sequences at each end. The 3′
extensions left at the donor site can be used for repair either from homologous sequences located in the other copy as a fully repaired gene which
contains two adjacent P-element target site (top right), or by non-homologous end-joining for imprecise repair, which could generate products that
contain varying lengths of P-element-derived sequences as the imprecisely repaired condition (bottom right).
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disruption, single P-element insertions are only able to dis-
rupt 25% of Drosophila essential genes and about 40% of
the total annotated genes, according to the estimation
from the Berkeley Drosophila Genome Project (BDGP)
[30,31]. Using piggyBac and Minos has significantly im-
proved the mutagenesis rate to 60% of the genome [32].
However, the low frequency in piggyBac-mediated
imprecise excision has hindered them from further cre-
ating mutations in the genes of interest directly. Subse-
quently, the development of Minos-Mediated Integration
Cassette (MiMIC) for gene-targeting has improved this
weakness. In addition to the backbone of Minos, MiMIC is
modified to carry a gene trap cassette flanked by two
inverted ΦC31 attP sites. With Minos showing no insertion
site preference, targeting every Drosophila gene is feasible
and therefore this transposon could potentially accomplish
unbiased genome-wide mutagenesis [33]. Taking advantage
of ΦC31 attP sites, gene trap cassettes in MiMIC can be
easily swapped with any DNA sequence flanked with attB
sites by ΦC31 recombinase, allowing further genemodifications and genome editing [33]. For examples, a
florescence reporter can be introduced to tag the protein
expression and the effects of MiMIC insertions can be
reverted after excising the whole cassettes.
Homologous recombination
Mutagenesis via chemicals or transposons is used to cre-
ate mutations at random sites of the genome, and it has
to be followed with screenings to identify phenotypes of
interests. This type of classical forward genetic approach
has proved its way in identifying novel genes while, in
the opposite way, a gene can be specifically mutagenized
in a reverse genetic approach once the genome sequence
is available. The classical reverse genetic approach for
Drosophila utilizes the homologous recombination (HR)
to replace genomic DNA. HR regularly occurs at low
frequencies in normal cells and it repairs DSBs after
DNA damages thus increases genetic variation during
meiosis [34]. Some microbes also employ homologous
recombination to exchange genetic material between dif-
ferent strains [35].
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line harboring a donor DNA that is derived from a P-
element cassette, carrying DNA sequences homologous
to the target locus flanked FLP Recombinase Target sites
(FRTs) and I-SceI recognition site(s). Two enzymes, the
site-specific recombinase FLP and endonuclease I-SceI
[36,37], are subsequently introduced into the Drosophila
line in order to create DSBs in an inserted donor trans-
gene. The recombination between two FRT sites excises
the cassette out from the original site and the cleavage
at the I-SceI recognition site(s) creates a DSB, which in-
duces the homology repair machinery that results in HR
between the donor DNA and the targeted chromosomal
sequence [38]. The arrangement of homologous sequences
and I-SceI sites in the donor DNA defines two targeting
strategies, Ends-In and Ends-Out, creating a tandem dupli-
cation or deletion of the target gene, respectively (Figure 2).
Although the Ends-Out targeting is successfully used in
mice for gene deletion, the frequency of Ends-Out targeting
is relatively low in Drosophila [39,40]. Ideally, candidates
are selected out by losing FRT sites; however, high false
positives are also documented due to damaged FRTs thattarget
Figure 2 The comparison of Ends-In and Ends-Out homologous recom
The major difference is whether the DSB is located within the region of ho
basic outcomes of these two methods. With ends-in (left), a break is made
in a tandem duplication of all the homologous sequence carried on the d
(in this case, the white+ and I-CreI site). In contrast, Ends-Out provides a sim
sequence. The result is to interrupt the targeted gene with a modified, heare not ruled out by the scoring method and interfere with
the efficiency of gene targeting [39]. A modified donor
DNA expressing reaper, a cell death gene, can eliminate
progenies that did not undergo recombination events and
therefore speed up the screening process [39]. Addition of
positive selection markers, such as the eye-specific 3xP3-
RFP to facilitate the screening, can also increase the re-
covery of correct knockout events [41]. On the other
hand, genome editing can be fulfilled by introducing the
donor DNA, carrying a desired modification to the site of
recombination via the Ends-In targeting strategy [42].
Combined the integration of attP site into the gene of
interest, repeated genome editing of that gene can
be accomplished through the following runs of ΦC31-
dependent recombination events [43]. Although it is labor-
intensive, this Ends-In homologous recombination has
been a reliable method for Drosophila genome editing.
Because of the limitations in the replication and trans-
position of P-elements, the size of donor DNA is limited to
approximately 30 kb. The P[acman] vector harbors dual
replication origins for maintaining large DNA sequences
and for inducing to high copy numbers. Therefore,target
bination. Ends-In and Ends-Out are two paradigms for gene targeting.
mology (Ends-In) or at the ends (Ends-Out). The figure compares the
within the region of homology. Recombination with the target results
onor, separated by any sequences that are between the FRT sites
ple replacement event between the genome and the homologous
terologous sequence, such as the w+ marker (right).
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100 kb via recombineering-mediated gap repair using
Bac or P1 genomic clones as templates [43]. Addition-
ally, ΦC31 integrase-mediated transgenesis significantly
increases the efficiency of integrating P[acman] plas-
mid into the fly genome. Further modifications have
advanced the applications of P[acman] in gene target-
ing and alterations. For examples, the employment of
the Gateway system not only facilitates the tagging, but
also provides a platform to knock out genes systematic-
ally; the introduction of selection markers, such as the
eye-specific 3xP3-RFP that mentioned above, eases the
screening process; and the combination of Cre-loxP
systems allows the removal of the targeting cassettes
and therefore reverts the mutations [44].
Although I-SceI-mediated homologous recombination
opens the door for scientists to disrupt target genes spe-
cifically, the low recombination frequency and numerous
false-positives have limited this technique from large
screenings. Newer methods, including ZFN, TALEN and
CRISPR/Cas9, involve the creating DSBs by nucleases
directly in genomic DNA, different from the DSBs gen-
erated by SceI that are created in extrachromosal donor
DNA. In the presence of genomic DSBs, different repair
machineries are employed based on the availability of
the homologous template. NHEJ functions by directly
joining the two ends of a DSB is the favored way when a
homologous template is absent [45]. Because NHEJ-
dependent repair ignores DNA deletion or insertion in
DSB sites, frame-shift mutations are sometimes created
[46]. Alternatively, DSBs can also be repaired through
HR either relying on the other copy of undamaged
chromosome in a diploid organism or using an exogen-
ous DNA fragment as a template. In the latter case, a
donor DNA sequence with homology arms is specifically
introduced into the target gene, which results in gene
modification in a base pair-precise manner [47].
ZFN and TALEN
ZFN and TALEN are artificial chimeric enzymes that
contain a DNA binding domain and a Fok1 DNA-
cleavage domain (Figure 3A-B). With the DNA cleavage
action itself showing no sequence preference, the specifi-
city of ZFN and TALEN is determined by their DNA-
binding domains, which can be engineered to recognize
specific sequence in the gene of interest. Each Zinc-
finger domain consists of approximately 30 amino acids
that bind to 3 base pairs of nucleotides. Instead, TALEN
uses the DNA-binding domains from transcription
activator-like effectors (TALEs) and recognizes a single
base pair. Therefore, linking multiple Zinc-fingers or
TALE repeats are required to create a long DNA recog-
nition sequence and increase the specificity of gene tar-
geting. The mutagenesis efficiency of ZFN-induced genetargeting in Drosophila has been estimated to be as high
as 1–10% at several loci including ry, coil and pask genes
[47,48]. A test at the y locus via ZFN-targeting has
proved that DSBs can enhance the efficiency of gene tar-
geting over simply homologous recombination [47].
ZFN system has evidently facilitated researchers in the
aspect of manipulating the genes of interest; however, in
Drosophila and other organisms such as the zebrafish
[49] and Caenorhabditis elegans [50], the efficiency of
TALEN is superior to that of ZFN. Considering the fact
that each TALE targets a single nucleotide, it provides
better design flexibility than that of a Zinc-finger. More-
over, the length of spacers between DNA-binding sites is
less flexible in ZFN than those in TALEN that show
less effect on nuclease activity with either an extra or de-
leted base pair. The specificity of ZFN depends on the
affinity between the zinc-finger domain and the target
site; therefore, ZFN has to be designed for each specific
target. The short binding sites of ZFN increase the possi-
bility of off-target cleavage, which might result in ele-
vated DSBs events in the cells and cause cell death [51].
Even though TALEN outranks ZFN in many ways, it is
speculated that TALEN does not release the ends imme-
diately after cleavage and may interfere with the onset of
DNA repair [52].
Cas9, sgRNA mediated high specificity for gene
interruption
Although ZFN and TALEN have demonstrated signifi-
cant advances in the technology of gene targeting, they
still require a new design for each gene, unaccommodat-
ing for systematic gene-disruption. CRISPR/Cas9 uses a
small guide RNA (sgRNA) to target DNA, dramatically
lowers the difficulties for site-specific gene modification.
CRISPR/Cas9 is currently considered the most popular
tool in the genome-editing era. The system, which origi-
nated as a component of prokaryotic innate immunity
system [55], recognizes target loci via sgRNA sequence:
this 20-bp sgRNA requires an adjourning NGG sequence
known as the protospacer adjacent motif (PAM) site for
Cas9 recognition [56-58] (Figure 3C). In brief, the edit-
ing efficiency of Cas9 to a target gene is deeply related
to the selection of sgRNA, including the distance be-
tween its cleavage site and the translation start site, the
GC content, the strand selection and the last four nucle-
otides before the PAM site of the sgRNA. All of the fac-
tors listed here should be taken into consideration to
enhance the performance of Cas9-mediated genome
editing [59].
Cas9 has grown in popularity for Drosophila gene
modification because of the following advantages over
other methods. First, both ZFN and TALEN require the
engineering of proteins for the specificity of gene target-
ing; instead, a change in 20-bp sgRNA is sufficient for
A B
C D
Figure 3 Site-specific endonucleases. Three classic site-specific endonucleases including ZFN, TALEN and CRISPR/Cas9 are shown. (A) ZFN simply
consists of a Zinc-finger protein (ZFP) fused to Fok1 endonuclease. The sequence composition of the α-helix in the zinc-finger determines the nucleotide
binding specificity of the ZFP. As a result, a ZFP chain can be created by joining a few ZFPs together and generating high specificity, allowing Fok1
endonuclease to accurately cleave DNA at the target site. (B) The C-terminal end of a TALE contains a Fok1 endonuclease for DNA cleavage. The central
part of the TALE contains a number of almost similar repeats that mediate specific binding to target loci in the genome, and each of these repeats
specifically binds to one base of the target DNA via two amino acids named repeat variable di-residues (RVDs), including NG, NI, HD and HN (or NK) for
recognizing one of the four different nucleotides: T, A, C and G, respectively [53,54]. (C) Cas9 forms a sequence-specific endonuclease when complexed
with the sgRNA. The Cas9/sgRNA complex then recognizes the targeted sequence, 20-bp in length, ending with two guanines (NGG) called the PAM
site. Cleavage occurs on both strands upstream of the PAM sites. (D) The DSB is first induced by ZFN, TALEN or Cas9 endonuclease and then repaired
by three possible mechanisms. When repaired by NHEJ, random deletions would occur at the site (left). When the repair is done by the endogenous
template within the genome, the sequence would be fully repaired (middle). If an exogenous modified template is added, the sequence could be
altered after repair, which is regarded as the gene editing (right).
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dant in the fly genome. Second, several methods have
been tested to deliver the Cas9 system to fly embryos:
(1) introducing of plasmid vectors or in vitro transcribed
RNA encoding Cas9 and sgRNA [60]; (2) injecting
sgRNA plasmid DNA into Cas9 transgenic flies, which
significantly increases the editing flexibility and effi-
ciency [17]; (3) establishing a transgenic model of Cas9-
sgRNA complex, which shows higher efficiency and sta-
bility [61]. Third, similar to P[acman], the introduction
of selection markers, such as coinjection of a donor vec-
tor carrying 3xP3-RFP (or 3xP3-DsRed), with Cas9 can
speed up the screening process and Cas9 can create con-
ditional knock-out lines when combined with theCre-loxP system [60,62]. These exogenous DNA (3xP3-
RFP/3xP3-DsRed or loxP sequence, for examples) are
flanked with homology arms about 1 kb long in both
ends on the donor plasmid for efficient knock-in [60,62],
and in this way, Cas9-based knock-in has shown better
successful rate compared with previous Ends-In
techniques [42]. Furthermore, Cas9 can be used as an al-
ternative tactic to create deletion mutations from the pre-
existing P-element insertions [60]. With the efficiency up
to 88% of injected embryos having mutations, Cas9 can
generate mutations rapidly [16]. One thing worthy of at-
tention is the off-target effects when using Cas9-based ap-
proaches. The target binding capacity of Cas9 remains the
same with 1-3 bp mismatches in target sequence unless
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nificantly different from that of TALEN, which can only
tolerate 1-2 bp mismatches [57]. Even though both
TALEN and Cas9 can accommodate some mismatches
in target sequence, it has been shown that Cas9 has
more off-target problems in the mammalian genome
[63,64]. High concentration of sgRNA has been shown
to impair Cas9 targeting [64]. It is possible that, in
some cases, the off-target effects may outweigh the ease
of construct design of the Cas9 system. Different gene
disruption strategies should be carefully compared be-
fore each project based on the context of targets and
the goal of the project.
Conclusions
Since Thomas Morgan and follow researchers have charac-
terized and studied the heritable mutants of thousands of
fruit flies, Drosophila has served as a key model system in
a wide range of biological researches. The new resources
and strategies for gene disruption will undoubtedly con-
tribute to the understanding at the systematic complexity
of the gene networks in this small yet sophisticated organ-
ism, and to the molecular mechanisms underlying these
important biological processes. The pros and cons are dis-
cussed above. EMS mutagenesis provides an unbiased
screen platform but is labor-intensive. P-elements are easy
to trace and to manipulate, but their preference for inser-
tion sites is far from being random. The method involving
HR is site-specific but relatively less efficient; however, the
combination of ZFN, TALEN or CRISPR/Cas9 with hom-
ologous recombination has made the editing efficiency
more promising. While gene targeting is simplified by the
use of CRISPR/Cas9, it is now feasible to establish a
disrupting library that covers all annotated protein-
coding genes in Drosophila melanogaster. With the goal
of producing a whole-genome mutant collection, scien-
tists have declared the capacity to generate deletion
mutants in 50–100 genes per month with an average
turnaround time of two months [65]. With the com-
bined efforts of multiple laboratories, it would be pos-
sible to generate all of the mutants in a few years, and
permit the functional dissection of individual genes in
clean genetic knockout background.
The manipulation of exogenous DNA templates in the
Cas9 cleavage site could be versatile (Figure 3D). This
“knock-in” process allows the generation of a conditional
knockout allele by introducing loxP sites, the analysis of
the expression pattern by inserting a traceable marker,
or the generation of point mutations in the endogenous
locus for the structure-function analysis. Together, these
genetic tools are valuable assets for researchers not only
to uncover the physiological functions of Drosophila
genes, but also to offer insights to decipher the complex
mechanisms of human biology and diseases in the future.Abbreviations
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